2Schiavi S,Kumar R.The phosphastonin pathway:New insights in phosphate homeostasis.Kidiney Int,2004,65:1-14.
3Shimada T,Mizutani S,Muto T,et al.Cloning and characterization of FGF-23 as a causative factor of tumor induced osteomalacia.Proc Nath Acad sci USA,2001,98:6500-6505.
4Shimada T,Urakawa I,Yamazaki Y,et al.FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type Ⅱ a.Biochem Biophys Res Commun,2004,314:409-414.
5Jonnson KB,Zahrasdnik R,Larsson T,et al.Fibroblast growth factor23 in oncogenic osteomalacia and X-linked hypophosphatemia.N Engl J Med,2003,348:1656-1663.
6Yamazski Y,Okazki R,Shibata M,et al.Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia.J Clin Endocrinol & Metab,2002,87:4957-4960.
8Shimada T,Kakitani M,Yamazaki Y,et al.Targeted ablation of FGF-23 demonstrate an essential physiological role of FGF 23 in phosphate and vitamin D metabolism.J Clin Invest,2004,113:561-568.
10Tanji N, TanjiK, K ambham N, et al. Adefovir neph ro- tox ic ity: possible role of mitochondrial DNA dep le tion[J]. H umPatho, 2001, 32 (7): 734 740.
